It belongs to a relatively new class of drugs called antibody-drug conjugates. <a href="https://fortune.com/2022/06/05/enhertu-her2-negative-low-breast-cancer-drug-could-help-more-patients-researchers-say-it-makes-for-the-first-time-a-targetable-population/">Read More</a>